(e) Strengthening pharmaceutical policies and practices, including those applicable to generic drugs and intellectual property regimes, in order to further promote innovation and the development of domestic industries consistent with international law;
(e) 加强药品政策和做法，包括适用于非专利药品和知识产权制度的政策和做法，以便进一步促进创新，和促进国内制药业在符合国际法下的发展；